EUVIMEDEUVIMED entdecken
Crossref

Yuvezzi — A Carbachol/Brimonidine Solution for Presbyopia

The Medical Letter on Drugs and Therapeutics · 25.05.2026 · 68 (1755) · 84-85

DOI: 10.58347/tml.2026.1755b ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Medical Letter on Drugs and Therapeutics, online erschienen am 25.05.2026.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The FDA has approved Yuvezzi (Tenpoint), an ophthalmic solution containing the cholinergic agonist carbachol 2.75% and the alpha-adrenergic receptor agonist brimonidine 0.1%, for treatment of presbyopia. Carbachol and brimonidine have been available in single-ingredient ophthalmic solutions for other indications for years.

Schlagwörter

Stichwörter der Autor:innen

QlosiVizzVuityYuvezziaceclidineadverse effectscarbachol/brimonidinedosageefficacyeyepilocarpinepresbyopiasafety

Zitieren

APA

(2026). Yuvezzi — A Carbachol/Brimonidine Solution for Presbyopia. The Medical Letter on Drugs and Therapeutics, 68(1755), 84-85. https://doi.org/10.58347/tml.2026.1755b

Vancouver

Yuvezzi — A Carbachol/Brimonidine Solution for Presbyopia. The Medical Letter on Drugs and Therapeutics. 2026;68(1755):84-85. doi:10.58347/tml.2026.1755b

BibTeX
@article{euvimed2026,
  title = {Yuvezzi — A Carbachol/Brimonidine Solution for Presbyopia},
  journal = {The Medical Letter on Drugs and Therapeutics},
  year = {2026},
  volume = {68},
  number = {1755},
  pages = {84--85},
  doi = {10.58347/tml.2026.1755b}
}
Kostenlos starten →